Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation

doi:10.5500/wjt.v14.i2.90571

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (493)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

HTML

316

Figures (1-1)

Tables (1-3)

Sum=427

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=44

Jun 18, 2024 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Transplantation

ISSN

2220-3230

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Transplant. Jun 18, 2024; 14(2): 90571
Published online Jun 18, 2024. doi: 10.5500/wjt.v14.i2.90571

Table 2 Dropout due to tumor progression in the treatment groups, n (%)

	Dropout due to tumor progression
		No	Yes
TACE	TACE only	33 (82.5)	7 (17.5)
	TACE + PEI	20 (80)	5 (20)
	Overall TACE	53 (81.5)	12 (18.5)
TAE	TAE only	19 (90.5)	2 (9.5)
	TAE + PEI	16 (94.1)	1 (5.9)
	Overall TAE	35 (92.1)	3 (7.9)

Fisher’s exact test for comparison of the four groups [transarterial chemoembolization (TACE) only, TACE + percutaneous ethanol injection (PEI), transarterial embolization (TAE) only, and TAE + PEI]: P = 0.565. Fisher’s exact test for comparison of the two groups (Overall TACE vs overall TAE): P = 0.162. TACE: Transarterial chemoembolization; TAE: Transarterial embolization; PEI: Percutaneous ethanol injection.

Citation: Lazzarotto-da-Silva G, Scaffaro LA, Farenzena M, Prediger L, Silva RK, Feier FH, Grezzana-Filho TJM, Rodrigues PD, de Araujo A, Alvares-da-Silva MR, Marchiori RC, Kruel CRP, Chedid MF. Transarterial embolization is an acceptable bridging therapy to hepatocellular carcinoma prior to liver transplantation. World J Transplant 2024; 14(2): 90571
URL: https://www.wjgnet.com/2220-3230/full/v14/i2/90571.htm
DOI: https://dx.doi.org/10.5500/wjt.v14.i2.90571